Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection - Wikidata - wikimedia - TriplyDB

Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection

Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection

http://www.wikidata.org/entity/Q30386608

about

Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature Bipolar disorder and mechanisms of action of mood stabilizers Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes Antipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanisms Aripiprazole: from pharmacological profile to clinical use Preclinical models of antipsychotic drug action.Recent advances in quantitative neuroproteomics Neuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophrenia Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future A longitudinal study of alterations of hippocampal volumes and serum BDNF levels in association to atypical antipsychotics in a sample of first-episode patients with schizophrenia Preliminary Safety Assessment of New Azinesulfonamide Analogs of Aripiprazole using Prokaryotic Models Antipsychotic drugs on maternal behavior in rats.Adult response to olanzapine or clozapine treatment is altered by adolescent antipsychotic exposure: a preclinical test in the phencyclidine hyperlocomotion model Smoking in schizophrenic patients: A critique of the self-medication hypothesis.Deletion of GSK3β in D2R-expressing neurons reveals distinct roles for β-arrestin signaling in antipsychotic and lithium action.Preweaning sensorimotor deficits and adolescent hypersociability in Grin1 knockdown mice.Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery.HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity.Contextual and behavioral control of antipsychotic sensitization induced by haloperidol and olanzapine Is the acute NMDA receptor hypofunction a valid model of schizophrenia?Dopamine D(2) receptor function is compromised in the brain of the methionine sulfoxide reductase A knockout mouse Behavioral and molecular neuroepigenetic alterations in prenatally stressed mice: relevance for the study of chromatin remodeling properties of antipsychotic drugs c-Fos identification of neuroanatomical sites associated with haloperidol and clozapine disruption of maternal behavior in the rat.General anesthesia and altered states of arousal: a systems neuroscience analysis.Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.Epigenetic signaling in schizophrenia An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes.New functional activity of aripiprazole revealed: Robust antagonism of D2 dopamine receptor-stimulated Gβγ signaling Structure-based discovery of low molecular weight compounds that stimulate neurite outgrowth and substitute for nerve growth factor International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes Intracerebral adult stem cells transplantation increases brain-derived neurotrophic factor levels and protects against phencyclidine-induced social deficit in mice.Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls.Hippocampal shape and volume changes with antipsychotics in early stage psychotic illness.Persistent effects of chronic clozapine on the cellular and behavioral responses to LSD in mice Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function.New Pharmacotherapy Targeting Cognitive Dysfunction of Schizophrenia via Modulation of GABA Neuronal Function Repressive epigenetic changes at the mGlu2 promoter in frontal cortex of 5-HT2A knockout mice.T-817MA, but Not Haloperidol and Risperidone, Restores Parvalbumin-Positive γ -Aminobutyric Acid Neurons in the Prefrontal Cortex and Hippocampus of Rats Transiently Exposed to MK-801 at the Neonatal Period.Prenatal stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune system Time-dependence of risperidone and asenapine sensitization and associated D2 receptor mechanism.

P2860

Q22241267-E9B73B2E-A14B-469C-8333-B8FC6E4DFB96 Q22252332-3BFCBF42-C7C9-4B64-9C88-33E1715772D2 Q24606088-53D21935-CBCF-4421-8C16-FF53BC11AC8C Q26745506-B6C2B7CF-13EA-4F64-B1DD-FE6FD0DC4FC2 Q26778312-9A2DB162-C9C3-4772-B3FB-29EC163BFC1A Q26827502-980C157A-9E00-437E-97D5-FC7C7FA57713 Q27000073-AF3DBDF7-4D66-4745-9F87-AC469E0B9960 Q27026382-EB1FA307-824B-4299-8735-3556BA8B2EC8 Q28394341-86A4E660-1E81-4F2D-88CD-1C3B33FCAAE4 Q28539784-F135E298-0EAD-419A-B69D-643FEAF1EFE6 Q28821520-4D474C63-CDCE-4D6E-94EA-7174587CD69B Q30375083-E6F173A7-593A-46D8-AD76-698E1193980A Q30386851-3DAF4B79-EE1D-45AD-AC22-B0A8D9B14903 Q30416030-3D038B6B-81B9-4E3B-A3E3-6FE334A58F64 Q30453635-78FC9473-E911-4290-9EEE-9BEAB492F87A Q30454766-DF777C7D-83F3-484A-A171-015896A3D179 Q30454958-2F6E2229-CF24-4C2A-A214-5BC7EC3A9CE5 Q30457800-6E5B517A-26E1-4DC2-8534-4388FBA84973 Q30458533-4489D362-48E6-46EB-9E7B-355BEDDB249D Q30459655-0F82676B-4331-4E65-9B25-AEF68C59FD37 Q30496436-CFF601F8-1DF1-45EE-B628-5A85D52928DB Q30823912-3094863B-ABAC-451B-968A-2D3C38D7AA30 Q33725056-215AAC56-624F-41EE-9057-28E3CC3CE5DB Q34179988-1451177A-DA35-457B-9855-62970198E4F3 Q34274859-F63F1786-8BC5-46A8-9E08-0022ACAEBB7F Q34482708-381BA98B-0595-46E5-B7E5-5AEC78A4A7A8 Q34541215-549517A7-5C0B-4245-8F52-EA8C5ED09CA6 Q34772251-17DF83C9-B1FD-496A-BD40-B3F1F793C053 Q34993652-911022C0-B3BE-499C-BA75-64FBF9A6537C Q35024730-1ED42037-2CA5-48C9-A0F1-6242371C534D Q35844158-4FD9104B-8F64-4E05-A71A-DDDBD59C0F16 Q36043389-5CE9E93F-9724-4130-8D68-6644C4174CDC Q36390750-451BC6F2-50AD-44E0-8A4E-E4B88EF8EEBC Q36555130-52B3A8DB-356C-4028-86D6-2E14496A5E1D Q36590407-F3BCB616-27DD-4486-B5CC-1FB84F3D51C1 Q36594948-A2F22A55-B63A-4150-8334-D568C5282CA4 Q36852536-BED9B02A-FA96-41A9-A2A3-6B2572553E1C Q36857587-3B5ACCB7-277F-4458-BB51-B35C36DE40D3 Q37013377-009244DE-EFA6-4134-8FEB-59AB6F310AAD Q37338151-F2AF4B40-3DC0-457F-8B2F-65EE31E82C35

P2860

Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection

http://www.wikidata.org/entity/Q30386608

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Antipsychotic drugs: compariso ...... egulation, and neuroprotection

@ast

Antipsychotic drugs: compariso ...... egulation, and neuroprotection

@en

type

label

Antipsychotic drugs: compariso ...... egulation, and neuroprotection

@ast

Antipsychotic drugs: compariso ...... egulation, and neuroprotection

@en

prefLabel

Antipsychotic drugs: compariso ...... egulation, and neuroprotection

@ast

Antipsychotic drugs: compariso ...... egulation, and neuroprotection

@en

P1433

Q30386608-920F9D57-3AF1-4709-BDEF-E503DFF2F2C3

P1476

Q30386608-7434E720-00EE-4166-A5B8-14D458CA0F22

P2093

Q30386608-2CA346EB-7664-4B5E-913F-C245DD52AA3C

Q30386608-3B8BFAAB-1EBB-4C83-98A4-ABBA51779C32

Q30386608-4072726F-C788-41F4-A853-9416BE239D3C

Q30386608-5D75E289-F746-4689-9CDF-B39CD57BC29D

Q30386608-86AB6B6A-171E-4F12-929F-51E1247E8D98

Q30386608-8E3F01BA-1E09-4304-85A9-A5A0F4208FE9

Q30386608-93074FD1-918D-4446-AD65-123207D576DF

Q30386608-939D0BC3-CD35-4143-A05B-8EA9A9A84D75

Q30386608-9BFDA6F7-4411-4FED-8793-07CA5C2BC6DC

Q30386608-AA51C9DB-93D3-4955-BA0D-7A4CE4524994

P2860

Q30386608-004C466E-FC47-48C8-A22D-D9A1E3818080

Q30386608-00C13A28-2F4D-4CEB-AF20-53F4A1037484

Q30386608-021B4019-C869-4055-BF19-B4BB99E81819

Q30386608-02554CE5-DA5C-4FC5-A312-13E71BDFB1D8

Q30386608-025EFA01-9ED8-4594-B6E0-ACEAB7EFA991

Q30386608-02A7DCCE-4D57-414C-9CAD-EC69145A02DF

Q30386608-02AE674F-AE41-42B3-B399-7C1D3FB97866

Q30386608-0343819D-9979-4012-827E-EE1C54BCB9FA

Q30386608-03787D6E-8070-4F93-B519-5F416674CF40

Q30386608-03AACF82-0154-4CB3-BAC8-C141F275C2B7

P304

Q30386608-DB01F49D-E34F-4373-92FF-A633626AE8C2

P31

Q30386608-EA7E571F-4469-430D-874A-634E9BC05936

P356

Q30386608-7D6BA078-12ED-48FD-9CA6-66F4ACD6E7CD

P407

Q30386608-53A74206-06AF-455C-B523-A6EA5E28E79D

P433

Q30386608-330E1E24-2A59-4BF1-9141-78833D89704B

P478

Q30386608-468258F7-94A5-486D-9ADA-931785043EF0

P577

Q30386608-3B291F88-0515-4CB3-B5E2-C9A08934AB52

P698

Q30386608-5CFF2556-FB7B-449B-B8AE-5C05FD2F061C

P921

Q30386608-332465DF-7216-42D9-B688-0CBBF0B9C957

P932

Q30386608-8A5569E8-E039-4289-A226-9DD201F50A43

P356

P1433

Pharmacological Reviews

P1476

Antipsychotic drugs: compariso ...... egulation, and neuroprotection

@en

P2093

Ariel Y Deutch

http://www.w3.org/2001/XMLSchema#string

Christine E Marx

http://www.w3.org/2001/XMLSchema#string

Donard S Dwyer

http://www.w3.org/2001/XMLSchema#string

Frank P Bymaster

http://www.w3.org/2001/XMLSchema#string

Gary E Duncan

http://www.w3.org/2001/XMLSchema#string

Herbert Y Meltzer

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Lieberman

http://www.w3.org/2001/XMLSchema#string

John G Csernansky

http://www.w3.org/2001/XMLSchema#string

Joseph H Porter

http://www.w3.org/2001/XMLSchema#string

Josephine S Modica-Napolitano

http://www.w3.org/2001/XMLSchema#string

P2860

d-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia

The neuregulin-I/ErbB signaling system in development and disease

An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior

Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis

In psychosis, cortical interneurons overexpress DNA-methyltransferase 1

DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains

Neural synchrony in schizophrenia: from networks to new treatments

Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice

Supply and demand in cerebral energy metabolism: the role of nutrient transporters

Adrenergic pharmacology and cognition: focus on the prefrontal cortex

P304

358-403

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/PR.107.00107

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18922967

http://www.w3.org/2001/XMLSchema#string

P921

neurotransmitter

P932

4821196

http://www.w3.org/2001/XMLSchema#string